Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NKT3964 |
Synonyms | |
Therapy Description |
NKT3964 is a proteolysis-targeted chimera (PROTAC) that targets CDK2 for degradation, potentially resulting in decreased tumor cell proliferation and antitumor activity (Eur J Cancer 211 (2024): 114453). |